ASCI is a new, Antigen Specific Cancer Immunotherapy approach
- The access to this website is restricted to healthcare professionals. If you want to get full access, please login or register below.
Welcome to the ASCI website dedicated to healthcare professionals
Antigen Specific Immunotherapeutics or ASCI is a novel approach to cancer treatment that aims at treating cancer through the targeting of cancer-specific antigens.
ASCI aims to re-stimulate the patients own immune response to selectively destroy tumor cells and is currently being evaluated in a large scale Phase III for the adjuvant treatment of Non-Small Cell Lung Carcinoma.
Learn more about the ASCI science and the targeted cancer types
Cancer is the result of the patient's immune system that has failed to eliminate cancerous cells. Cancer immunotherapy builds on the presence of various types of cancer antigens and encompasses a range of different specific and non-specific approaches and techniques that aims at stimulating and enhancing the natural immune response to malignant cells to ultimately destroy them.
Discover the anti-cancer immune response, cancer-antigens and the different types of cancer immunotherapy
Please fill in the form with your username, your password will be send to your registered e-mail.
* Mandatory fields
Welcome to www.gsk-asci.com
If this is your first time at this site, please click here to register.
Register now
Why register?
For legal reasons, this page is intended solely for healthcare professionals. This is why we ask you to register.